Literature DB >> 4971054

Chronic cholangitides: aetiology, diagnosis, and treatment.

S Sherlock.   

Abstract

A number of different chronic diseases affect the intrahepatic bile radicles or cholangioles. They include primary and secondary sclerosing cholangitis, primary biliary cirrhosis, chronic cholestatic drug jaundice, atresia, and carcinoma. Aetiological factors include infection, immunological changes, hormones, and congenital defects.Patients with chronic cholestasis have decreased bile salts in the intestinal contents and suffer from a bile salt deficiency syndrome. Failure to absorb dietary fat is managed by a low-fat diet and by medium-chain trigly-cerides which are absorbed in the absence of intestinal bile salts. Fat-soluble vitamin deficiencies are prevented by parenteral vitamins A, D, and K(1). Calcium absorption is defective, and improvement may follow intramuscular vitamin D, medium-chain triglycerides, a low-fat diet, and oral calcium supplements.In partial intestinal bile salt deficiency the anionic bile-salt-chelating resin cholestyramine controls pruritus though steatorrhoea increases. Pruritus associated with total lack of intestinal bile salts is managed by methyl-testosterone or norethandrolone, though the jaundice increases.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4971054      PMCID: PMC1986450          DOI: 10.1136/bmj.3.5617.515

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  40 in total

1.  Incidence of haemagglutinating and complement-fixing antibodies.

Authors:  G L ASHERSON; O BROBERGER
Journal:  Br Med J       Date:  1961-05-20

2.  THE SPECTRUM OF CHOLESTATIC HEPATIC DISEASE.

Authors:  M H STAUFFER; W G SAUER; W H DEARING; A H BAGGENSTOSS
Journal:  JAMA       Date:  1965-03-08       Impact factor: 56.272

3.  Anti-cytoplasmic factors in the sera of patients with systemic lupus erythematosus and certain other diseases.

Authors:  H R DEICHER; H R HOLMAN; H G KUNKEL
Journal:  Arthritis Rheum       Date:  1960-02

4.  Primary billiary cirrhosis (chronic intrahepatic obstructive jaundice).

Authors:  S SHERLOCK
Journal:  Gastroenterology       Date:  1959-11       Impact factor: 22.682

5.  Immunoglobulins in chronic liver disease.

Authors:  T Feizi
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

6.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

7.  Effect of long-term tetracycline therapy, steroid therapy and colectomy in pericholangitis associated with ulcerative colitis.

Authors:  S P Mistilis; A P Skyring; S J Goulston
Journal:  Australas Ann Med       Date:  1965-11

8.  Liver in ulcerative colitis: obstructive jaundice due to bile duct carcinoma.

Authors:  J G Rankin; A P Skyring; S J Goulston
Journal:  Gut       Date:  1966-10       Impact factor: 23.059

9.  Production of bile duct hyperplasia and gallstones by lithocholic acid.

Authors:  R H Palmer; Z Ruban
Journal:  J Clin Invest       Date:  1966-08       Impact factor: 14.808

10.  The effect of bile, bile acids and detergents on calcium absorption in the chick.

Authors:  D D Webling; E S Holdsworth
Journal:  Biochem J       Date:  1965-11       Impact factor: 3.857

View more
  5 in total

1.  Recent advances in jaundice. Surgical aspects.

Authors:  J L Dawson
Journal:  Br Med J       Date:  1970-01-24

2.  Sclerosing cholangitis and primary biliary cirrhosis--a disease spectrum?

Authors:  H J Fee; H Gewirtz; J Schiller; W P Longmire
Journal:  Ann Surg       Date:  1977-11       Impact factor: 12.969

3.  Occurrence of an abnormal lipoprotein in patients with liver disease.

Authors:  A Ross; G M Murphy; P A Wilkinson; G L Mills; S Sherlock
Journal:  Gut       Date:  1970-12       Impact factor: 23.059

4.  Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients.

Authors:  Silke Leonhardt; Wilfried Veltzke-Schlieker; Andreas Adler; Eckart Schott; Roland Hetzer; Walter Schaffartzik; Michael Tryba; Peter Neuhaus; Daniel Seehofer
Journal:  Crit Care       Date:  2015-03-31       Impact factor: 9.097

5.  Impact of hepatopathy in pediatric patients after surgery for complex congenital heart disease.

Authors:  Torben Kehl; Daniel Biermann; Andrea Briem-Richter; Gerhard Schoen; Jakob Olfe; Joerg S Sachweh; Lutz Fischer; Hansjoerg Schaefer; Rainer Kozlik-Feldmann; Urda Gottschalk
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.